netFormulary NHS
Pan Mersey
Area Prescribing Committee
 Formulary Chapter 7: Obstetrics, gynaecology, and urinary-tract disorders - Full Section

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Obstetrics, gynaecology, and urinary-tract disorders

Review date: Sept 2022

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

Medications which are indicated for medically assisted reproduction, including ovulation induction (e.g. clomifene, letrozole and tamoxifen) and assisted reproduction, such as In Vitro Fertilisation or Ex Vitro Fertilisation (e.g. gonadotrophins) are restricted to use by specialist secondary care physicians, and are categorised as RED drugs for these purposes.

 Useful Links

07.01 Drugs used in obstetrics
07.01.01 Prostaglandins and oxytocics Drugs affecting the ductus arteriosus
07.01.02 Mifepristone
07.01.03 Myometrial relaxants
07.02 Treatment of vaginal and vulval conditions
07.02.01 Preparations for vaginal and vulval changes
07.02.02 Vaginal and vulval infections
Fungal infections
Other vaginal infections
07.03 Contraceptives
07.03.01 Combined hormonal contraceptives
Emergency contraception
07.03.02 Progestogen-only contraceptives Oral progestogen-only contraceptives Parenteral progestogen-only contraceptives Intra-uterine progestogen-only contraceptive
07.03.03 Spermicidal contraceptives
07.03.04 Contraceptive devices
Intra-uterine devices
07.03.05 Emergency Contraception
Hormonal methods
07.04 Drugs for genito-urinary disorders
07.04.01 Drugs for urinary retention
07.04.02 Drugs for urinary frequency, enuresis, and incontinence
Urinary incontinence
Nocturnal enuresis
07.04.03 Drugs used in urological pain
Alkalinisation of urine
Acidification of urine
07.04.04 Bladder instillations and urological surgery
07.04.05 Drugs for erectile dysfunction
07.04.06 Drugs for premature ejaculation